1. Home
  2. Analysis
  3. Betapace-af

Betapace af side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Betapace af. Common side effects include alopecia among females, and amyotrophic lateral sclerosis among males.

The phase IV clinical study is created by eHealthMe based on 144 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 14, 2023

144 people who take Betapace Af and have side effects are studied.

What is Betapace Af?

Betapace af has active ingredients of sotalol hydrochloride. It is used in atrial fibrillation/flutter. Currently, eHealthMe is studying from 199 Betapace af users.

Number of Betapace af reports submitted per year:

Betapace af side effects.

Betapace af side effects by time on the drug *:

Click here to view

Betapace af side effects by gender *:

Click here to view

Betapace af side effects by age *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Betapace af?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

How the study uses the data?

The study is based on sotalol hydrochloride (the active ingredients of Betapace af) and Betapace af (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Betapace af:

All Betapace af side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.